⌘K

Login Start Free

Home/Filings/4/0001235645-05-000003

4//SEC Filing

MUELLER ALAN L 4

Accession 0001235645-05-000003

CIK 0000890465other

View on SEC.gov Company Profile

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 6:13 PM ET

Size

8.0 KB

Accession

0001235645-05-000003

Insider Transaction Report

Form 4

Period: 2005-02-03

NPS PHARMACEUTICALS INCNPSP

VP, Drug Discovery

Transactions

Award
Incentive Stock Option
2005-02-03$15.48/sh+2,486$38,483→ 2,486 total
Exercise: $15.48From: 2006-02-03Exp: 2015-02-03→ Common Stock (2,486 underlying)
Award
Non-Qualified Stock Option
2005-02-03$15.48/sh+6,389$98,902→ 6,389 total
Exercise: $15.48From: 2006-02-03Exp: 2015-02-03→ Common Stock (6,389 underlying)

Footnotes (1)

[F1]Stock option granted under the 1998 Stock Option Plan. The option becomes exercisable based on the following four-year vesting schedule: 28% on the first anniversary of the grant, and 2% each month thereafter.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

NPS PHARMACEUTICALS INC

CIK 0000890465

Entity typeother

Related Parties

1

filerCIK 0001235645

Filing Metadata

Form type: 4
Filed: Feb 6, 7:00 PM ET
Accepted: Feb 7, 6:13 PM ET
Size: 8.0 KB

View on SEC.gov